HEMISPHERE ENERGY CORP (HME.CA) Fundamental Analysis & Valuation

TSX-V:HME • CA4236301020

Current stock price

2.8 CAD
-0.04 (-1.41%)
Last:

This HME.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

9

1. HME.CA Profitability Analysis

1.1 Basic Checks

  • In the past year HME was profitable.
  • HME had a positive operating cash flow in the past year.
  • HME had positive earnings in 4 of the past 5 years.
  • HME had a positive operating cash flow in each of the past 5 years.
HME.CA Yearly Net Income VS EBIT VS OCF VS FCFHME.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 24.66%, HME belongs to the top of the industry, outperforming 98.10% of the companies in the same industry.
  • With an excellent Return On Equity value of 38.33%, HME belongs to the best of the industry, outperforming 98.57% of the companies in the same industry.
  • HME's Return On Invested Capital of 31.98% is amongst the best of the industry. HME outperforms 99.52% of its industry peers.
  • HME had an Average Return On Invested Capital over the past 3 years of 38.31%. This is significantly above the industry average of 6.65%.
  • The 3 year average ROIC (38.31%) for HME is well above the current ROIC(31.98%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 24.66%
ROE 38.33%
ROIC 31.98%
ROA(3y)27.91%
ROA(5y)18.35%
ROE(3y)41.42%
ROE(5y)28.93%
ROIC(3y)38.31%
ROIC(5y)29.36%
HME.CA Yearly ROA, ROE, ROICHME.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

1.3 Margins

  • The Profit Margin of HME (30.81%) is better than 95.71% of its industry peers.
  • In the last couple of years the Profit Margin of HME has grown nicely.
  • Looking at the Operating Margin, with a value of 42.73%, HME belongs to the top of the industry, outperforming 93.33% of the companies in the same industry.
  • HME's Operating Margin has improved in the last couple of years.
  • HME has a better Gross Margin (60.82%) than 80.00% of its industry peers.
  • HME's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 42.73%
PM (TTM) 30.81%
GM 60.82%
OM growth 3Y2.1%
OM growth 5Y4.69%
PM growth 3Y34.16%
PM growth 5Y45.92%
GM growth 3Y-1.38%
GM growth 5Y-1.19%
HME.CA Yearly Profit, Operating, Gross MarginsHME.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. HME.CA Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so HME is creating value.
  • HME has less shares outstanding than it did 1 year ago.
  • The number of shares outstanding for HME has been increased compared to 5 years ago.
  • HME has a better debt/assets ratio than last year.
HME.CA Yearly Shares OutstandingHME.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
HME.CA Yearly Total Debt VS Total AssetsHME.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

  • An Altman-Z score of 5.86 indicates that HME is not in any danger for bankruptcy at the moment.
  • HME has a Altman-Z score of 5.86. This is amongst the best in the industry. HME outperforms 85.71% of its industry peers.
  • HME has a debt to FCF ratio of 0.07. This is a very positive value and a sign of high solvency as it would only need 0.07 years to pay back of all of its debts.
  • HME's Debt to FCF ratio of 0.07 is amongst the best of the industry. HME outperforms 96.67% of its industry peers.
  • HME has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
  • HME has a better Debt to Equity ratio (0.03) than 76.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF 0.07
Altman-Z 5.86
ROIC/WACC4.02
WACC7.96%
HME.CA Yearly LT Debt VS Equity VS FCFHME.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

  • HME has a Current Ratio of 1.41. This is a normal value and indicates that HME is financially healthy and should not expect problems in meeting its short term obligations.
  • HME has a better Current ratio (1.41) than 69.52% of its industry peers.
  • HME has a Quick Ratio of 1.41. This is a normal value and indicates that HME is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.41, HME is in the better half of the industry, outperforming 70.95% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.41
Quick Ratio 1.41
HME.CA Yearly Current Assets VS Current LiabilitesHME.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. HME.CA Growth Analysis

3.1 Past

  • The earnings per share for HME have decreased by -9.09% in the last year.
  • HME shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 80.04% yearly.
  • The Revenue has decreased by -0.77% in the past year.
  • Measured over the past years, HME shows a very strong growth in Revenue. The Revenue has been growing by 25.97% on average per year.
EPS 1Y (TTM)-9.09%
EPS 3Y72.84%
EPS 5Y80.04%
EPS Q2Q%-22.22%
Revenue 1Y (TTM)-0.77%
Revenue growth 3Y32.32%
Revenue growth 5Y25.97%
Sales Q2Q%-13.24%

3.2 Future

  • Based on estimates for the next years, HME will show a very negative growth in Earnings Per Share. The EPS will decrease by -15.87% on average per year.
  • The Revenue is expected to decrease by -7.01% on average over the next years.
EPS Next Y-12.61%
EPS Next 2Y-7.35%
EPS Next 3Y-6.72%
EPS Next 5Y-15.87%
Revenue Next Year-5.85%
Revenue Next 2Y-6.12%
Revenue Next 3Y-4.8%
Revenue Next 5Y-7.01%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
HME.CA Yearly Revenue VS EstimatesHME.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 20M 40M 60M 80M 100M
HME.CA Yearly EPS VS EstimatesHME.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2022 2023 2024 2025 2026 2027 2028 0 0.1 0.2 0.3

More info and screens

Find the best growth stocksShow best growing peers

7

4. HME.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 9.33 indicates a reasonable valuation of HME.
  • Based on the Price/Earnings ratio, HME is valued cheaply inside the industry as 81.90% of the companies are valued more expensively.
  • When comparing the Price/Earnings ratio of HME to the average of the S&P500 Index (25.51), we can say HME is valued rather cheaply.
  • With a Price/Forward Earnings ratio of 9.89, the valuation of HME can be described as very reasonable.
  • HME's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. HME is cheaper than 78.57% of the companies in the same industry.
  • HME's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.76.
Industry RankSector Rank
PE 9.33
Fwd PE 9.89
HME.CA Price Earnings VS Forward Price EarningsHME.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • HME's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. HME is cheaper than 90.95% of the companies in the same industry.
  • HME's Price/Free Cash Flow ratio is rather cheap when compared to the industry. HME is cheaper than 93.33% of the companies in the same industry.
Industry RankSector Rank
P/FCF 6.05
EV/EBITDA 4.53
HME.CA Per share dataHME.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.2 0.4 0.6 0.8 1

4.3 Compensation for Growth

  • The excellent profitability rating of HME may justify a higher PE ratio.
  • HME's earnings are expected to decrease with -6.72% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.12
EPS Next 2Y-7.35%
EPS Next 3Y-6.72%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. HME.CA Dividend Analysis

5.1 Amount

  • HME has a Yearly Dividend Yield of 3.56%.
  • HME's Dividend Yield is a higher than the industry average which is at 4.54.
  • HME's Dividend Yield is rather good when compared to the S&P500 average which is at 1.89.
Industry RankSector Rank
Dividend Yield 3.56%

5.2 History

  • HME has been paying a dividend for over 5 years, so it has already some track record.
  • The dividend of HME decreased in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years2
Div Non Decr Years2
HME.CA Yearly Dividends per shareHME.CA Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 2026 0.05 0.1 0.15

5.3 Sustainability

  • HME pays out 60.59% of its income as dividend. This is not a sustainable payout ratio.
DP60.59%
EPS Next 2Y-7.35%
EPS Next 3Y-6.72%
HME.CA Yearly Income VS Free CF VS DividendHME.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M
HME.CA Dividend Payout.HME.CA Dividend Payout, showing the Payout Ratio.HME.CA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

HME.CA Fundamentals: All Metrics, Ratios and Statistics

HEMISPHERE ENERGY CORP

TSX-V:HME (3/31/2026, 7:00:00 PM)

2.8

-0.04 (-1.41%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)11-25
Earnings (Next)04-15
Inst Owners0.94%
Inst Owner ChangeN/A
Ins Owners16.08%
Ins Owner ChangeN/A
Market Cap264.12M
Revenue(TTM)98.24M
Net Income(TTM)30.27M
Analysts84
Price Target2.96 (5.71%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.56%
Yearly Dividend0.16
Dividend Growth(5Y)N/A
DP60.59%
Div Incr Years2
Div Non Decr Years2
Ex-Date02-12
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-2.91%
Min EPS beat(2)-2.91%
Max EPS beat(2)-2.91%
EPS beat(4)1
Avg EPS beat(4)-1.48%
Min EPS beat(4)-2.91%
Max EPS beat(4)2.8%
EPS beat(8)3
Avg EPS beat(8)-2.87%
EPS beat(12)5
Avg EPS beat(12)1.35%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)2.89%
Min Revenue beat(2)-0.21%
Max Revenue beat(2)5.99%
Revenue beat(4)3
Avg Revenue beat(4)2.9%
Min Revenue beat(4)-0.21%
Max Revenue beat(4)5.99%
Revenue beat(8)5
Avg Revenue beat(8)0.35%
Revenue beat(12)7
Avg Revenue beat(12)-0.67%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)13.73%
PT rev (3m)19.59%
EPS NQ rev (1m)20%
EPS NQ rev (3m)33.33%
EPS NY rev (1m)1.82%
EPS NY rev (3m)1.82%
Revenue NQ rev (1m)2.45%
Revenue NQ rev (3m)2.29%
Revenue NY rev (1m)-0.27%
Revenue NY rev (3m)-0.03%
Valuation
Industry RankSector Rank
PE 9.33
Fwd PE 9.89
P/S 2.69
P/FCF 6.05
P/OCF 4.75
P/B 3.35
P/tB 3.35
EV/EBITDA 4.53
EPS(TTM)0.3
EY10.71%
EPS(NY)0.28
Fwd EY10.12%
FCF(TTM)0.46
FCFY16.54%
OCF(TTM)0.59
OCFY21.04%
SpS1.04
BVpS0.84
TBVpS0.84
PEG (NY)N/A
PEG (5Y)0.12
Graham Number2.38
Profitability
Industry RankSector Rank
ROA 24.66%
ROE 38.33%
ROCE 42.48%
ROIC 31.98%
ROICexc 43.34%
ROICexgc 43.34%
OM 42.73%
PM (TTM) 30.81%
GM 60.82%
FCFM 44.47%
ROA(3y)27.91%
ROA(5y)18.35%
ROE(3y)41.42%
ROE(5y)28.93%
ROIC(3y)38.31%
ROIC(5y)29.36%
ROICexc(3y)41.04%
ROICexc(5y)31.02%
ROICexgc(3y)41.04%
ROICexgc(5y)31.02%
ROCE(3y)50.88%
ROCE(5y)39%
ROICexgc growth 3Y12.92%
ROICexgc growth 5Y20.01%
ROICexc growth 3Y12.92%
ROICexc growth 5Y20.01%
OM growth 3Y2.1%
OM growth 5Y4.69%
PM growth 3Y34.16%
PM growth 5Y45.92%
GM growth 3Y-1.38%
GM growth 5Y-1.19%
F-Score6
Asset Turnover0.8
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF 0.07
Debt/EBITDA 0.04
Cap/Depr 105.19%
Cap/Sales 12.1%
Interest Coverage 250
Cash Conversion 104.31%
Profit Quality 144.34%
Current Ratio 1.41
Quick Ratio 1.41
Altman-Z 5.86
F-Score6
WACC7.96%
ROIC/WACC4.02
Cap/Depr(3y)210.69%
Cap/Depr(5y)187.35%
Cap/Sales(3y)20.24%
Cap/Sales(5y)19.51%
Profit Quality(3y)104.52%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-9.09%
EPS 3Y72.84%
EPS 5Y80.04%
EPS Q2Q%-22.22%
EPS Next Y-12.61%
EPS Next 2Y-7.35%
EPS Next 3Y-6.72%
EPS Next 5Y-15.87%
Revenue 1Y (TTM)-0.77%
Revenue growth 3Y32.32%
Revenue growth 5Y25.97%
Sales Q2Q%-13.24%
Revenue Next Year-5.85%
Revenue Next 2Y-6.12%
Revenue Next 3Y-4.8%
Revenue Next 5Y-7.01%
EBIT growth 1Y-3.75%
EBIT growth 3Y35.09%
EBIT growth 5Y31.88%
EBIT Next Year34.08%
EBIT Next 3Y-0.98%
EBIT Next 5Y-5.77%
FCF growth 1Y130.83%
FCF growth 3Y57.01%
FCF growth 5YN/A
OCF growth 1Y39.86%
OCF growth 3Y36.33%
OCF growth 5Y34.82%

HEMISPHERE ENERGY CORP / HME.CA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of HEMISPHERE ENERGY CORP (HME.CA) stock?

ChartMill assigns a fundamental rating of 7 / 10 to HME.CA.


What is the valuation status for HME stock?

ChartMill assigns a valuation rating of 7 / 10 to HEMISPHERE ENERGY CORP (HME.CA). This can be considered as Undervalued.


What is the profitability of HME stock?

HEMISPHERE ENERGY CORP (HME.CA) has a profitability rating of 9 / 10.


Can you provide the financial health for HME stock?

The financial health rating of HEMISPHERE ENERGY CORP (HME.CA) is 8 / 10.


What is the earnings growth outlook for HEMISPHERE ENERGY CORP?

The Earnings per Share (EPS) of HEMISPHERE ENERGY CORP (HME.CA) is expected to decline by -12.61% in the next year.